Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Amino acid substitution in HCV core/NS5A region and genetic variation near IL28B gene affect treatment efficacy to interferon plus ribavirin combination therapy.
EGFR-based bioradiotherapy in SCCHN.
Phase I study of suramin administered by intermittent infusion without adaptive control to cancer patients: update of two expanded dose levels near the maximally tolerated dose.
Three hundred twenty-six genetic variations in genes encoding nine members of ATP-binding cassette, subfamily B (ABCB/MDR/TAP), in the Japanese population.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
EGFR-based bioradiotherapy in SCCHN.
EGFR-based bioradiotherapy in SCCHN. Lancet Oncol. 2015 Feb; 16(2):129-30.
View in:
PubMed
subject areas
Antineoplastic Combined Chemotherapy Protocols
Chemoradiotherapy
Female
Head and Neck Neoplasms
Humans
Male
Neoplasms, Squamous Cell
authors with profiles
Everett E. Vokes